{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:23:08Z","timestamp":1777350188713,"version":"3.51.4"},"reference-count":41,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIHR Applied Research Collaboration","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/100018336","name":"NIHR Health Protection Research Unit","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100018336","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UK Health Security Agency","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2024,10,9]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Liver disease is a growing cause of premature death in the UK. The National Health Service in England (NHS England) has funded regional early detection programmes through Community Liver Health Check pilots. \u2018Alright My Liver?\u2019 is Bristol and Severn\u2019s pilot service offering early detection of liver disease through screening events serving populations at risk, including people with a history of drug or alcohol use, type 2 diabetes and obesity. The service offers point-of-care testing for liver disease and a supported follow-up process.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Semistructured interviews were conducted with 14 service users and six service providers over a 6-month period using diversity sampling. Topic guides encouraged discussion of experiences of the service as well as barriers and facilitators to accessing the service. Data were analysed using thematic analysis, and positive and negative comments pertaining to the service were collated in a \u2018table of changes\u2019 to inform optimisation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Three main themes were identified: (1) motivations for engagement, (2) experience of the service and (3) health impacts. Key motivations for engagement were screening as a novel opportunity, a response to immediate health concerns or as reassurance. Service users commented on its convenience and that staff interactions were warm and informative. Some felt that follow-up could be more intensive. Impacts varied depending on perceived risk factors and screening results but generally involved stating a commitment to healthy lifestyle changes, including reducing alcohol use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Targeted screening for liver disease in high-risk groups through this pilot service was deemed an appropriate and accessible intervention, with important optimisations identified.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgast-2024-001560","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T02:00:21Z","timestamp":1731463221000},"page":"e001560","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Qualitative service evaluation of a multimodal pilot service for early detection of liver disease in high-risk groups: \u2018Alright My Liver?\u2019"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4185-4454","authenticated-orcid":false,"given":"Ann Jane","family":"Archer","sequence":"first","affiliation":[{"name":"Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"Department of Liver Medicine, Bristol Royal Infirmary, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"May","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"NIHR Health Protection Research Unit in Behavioural Science and Evaluation, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Bowers","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"NIHR Health Protection Research Unit in Behavioural Science and Evaluation, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Kesten","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"NIHR Health Protection Research Unit in Behavioural Science and Evaluation, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Tilden","sequence":"additional","affiliation":[{"name":"Department of Liver Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7301-8250","authenticated-orcid":false,"given":"Kushala","family":"Abeysekera","sequence":"additional","affiliation":[{"name":"Department of Liver Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"},{"name":"Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona H","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Liver Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"NIHR Health Protection Research Unit in Behavioural Science and Evaluation, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Yardley","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Bristol, UK"},{"name":"NIHR Health Protection Research Unit in Behavioural Science and Evaluation, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"2025073012505501000_11.1.e001560.1","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(14)61838-9","article-title":"Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis","volume":"384","author":"Williams","year":"2014","journal-title":"The Lancet"},{"key":"2025073012505501000_11.1.e001560.2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.14309\/ajg.0000000000000545","article-title":"Health-Related Quality of Life: A Rapid Predictor of Hospitalization in Patients With Cirrhosis","volume":"115","author":"Kok","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"2025073012505501000_11.1.e001560.3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Sepanlou","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025073012505501000_11.1.e001560.4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7861\/clinmed.2019-0250","article-title":"Decompensated cirrhosis is the commonest presentation for NAFLD patients undergoing liver transplant assessment","volume":"20","author":"Hussain","year":"2020","journal-title":"Clin Med (Lond)"},{"key":"2025073012505501000_11.1.e001560.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02716.x"},{"key":"2025073012505501000_11.1.e001560.6","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2021-101833"},{"key":"2025073012505501000_11.1.e001560.7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32163"},{"key":"2025073012505501000_11.1.e001560.8","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.30.2200738","article-title":"Estimates of hepatitis B virus prevalence among general population and key risk groups in EU\/EEA\/UK countries: a systematic review","volume":"28","author":"Bivegete","year":"2023","journal-title":"Euro Surveill"},{"key":"2025073012505501000_11.1.e001560.9","doi-asserted-by":"publisher","DOI":"10.1111\/add.14393"},{"key":"2025073012505501000_11.1.e001560.10","unstructured":"Government U . Liver disease profiles. 2021."},{"key":"2025073012505501000_11.1.e001560.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2025073012505501000_11.1.e001560.12","unstructured":"Archer AJ , Phillips J , Subhani M , et al . Proactive Case Finding of Alcohol-Related Liver Disease in High-Risk Populations: A Systematic Review. Liver International.n\/a(n\/a),"},{"key":"2025073012505501000_11.1.e001560.13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/alcalc\/agaa143","article-title":"Does Advice Based on Biomarkers of Liver Injury or Non-Invasive Tests of Liver Fibrosis Impact High-Risk Drinking Behaviour: A Systematic Review With Meta-analysis","volume":"56","author":"Subhani","year":"2021","journal-title":"Alcohol Alcohol"},{"key":"2025073012505501000_11.1.e001560.14","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"2025073012505501000_11.1.e001560.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.03.012"},{"key":"2025073012505501000_11.1.e001560.16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/135965350601100614","article-title":"Hepatitis B Virus Replication and Liver Disease Progression: The Impact of Antiviral Therapy","volume":"11","author":"Liaw","year":"2006","journal-title":"Antivir Ther (Lond)"},{"key":"2025073012505501000_11.1.e001560.17","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2023-102430"},{"key":"2025073012505501000_11.1.e001560.18","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp13X670642"},{"key":"2025073012505501000_11.1.e001560.19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1515\/jtim-2017-0017","article-title":"Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic","volume":"5","author":"Crowley","year":"2017","journal-title":"J Transl Int Med"},{"key":"2025073012505501000_11.1.e001560.20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.drugpo.2015.07.002","article-title":"Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study","volume":"26","author":"Marshall","year":"2015","journal-title":"Int J Drug Policy"},{"key":"2025073012505501000_11.1.e001560.21","doi-asserted-by":"publisher","DOI":"10.1111\/add.14569"},{"key":"2025073012505501000_11.1.e001560.22","unstructured":"England N . NHSE community liver health. 2023. Available: https:\/\/www.england.nhs.uk\/2023\/03\/nhs-on-the-spot-liver-scans-find-one-in-10-people-have-liver-damage-that-could-lead-to-deadly-cancer\/#:~:text=Checks%20are%20being%20offered%20in,risk%20of%20developing%20liver%20cancer"},{"key":"2025073012505501000_11.1.e001560.23","unstructured":"Archer A . Alright my liver? UHBW website. 2022. Available: www.UHBristol.nhs.uk\/AlrightMyLiver"},{"key":"2025073012505501000_11.1.e001560.24","unstructured":"Excellence NIfHaC . FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care (diagnostics guidance dg48)2023. 2023. Available: https:\/\/www.nice.org.uk\/guidance\/dg48"},{"key":"2025073012505501000_11.1.e001560.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025"},{"key":"2025073012505501000_11.1.e001560.26","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324243"},{"key":"2025073012505501000_11.1.e001560.27","doi-asserted-by":"crossref","unstructured":"Babor TF . A Cross-National Trial of Brief Interventions with Heavy Drinkers. Am J Public Health 1996;86. doi:10.2105\/AJPH.86.7.948","DOI":"10.2105\/AJPH.86.7.948"},{"key":"2025073012505501000_11.1.e001560.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(00)00189-1"},{"key":"2025073012505501000_11.1.e001560.29","doi-asserted-by":"crossref","unstructured":"Yardley L , Denford S , Kamal A , et al . The agile co-production and evaluation (ACE) framework for developing public health interventions, messaging and guidance. 2022. doi:10.31234\/osf.io\/rbn8m","DOI":"10.31234\/osf.io\/rbn8m"},{"key":"2025073012505501000_11.1.e001560.30","doi-asserted-by":"publisher","DOI":"10.1177\/1049732315617444"},{"key":"2025073012505501000_11.1.e001560.31","unstructured":"Joffe H , Yardley L . Content and thematic analysis. 2003."},{"key":"2025073012505501000_11.1.e001560.32","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-015-0033-z","article-title":"The person-based approach to enhancing the acceptability and feasibility of interventions","volume":"1","author":"Yardley","year":"2015","journal-title":"Pilot Feasibility Stud"},{"key":"2025073012505501000_11.1.e001560.33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041574","article-title":"Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluation","volume":"10","author":"Knight","year":"2020","journal-title":"BMJ Open"},{"key":"2025073012505501000_11.1.e001560.34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.drugpo.2017.06.001","article-title":"'I didn\u2019t want to let it go too far.' The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife study","volume":"47","author":"Marshall","year":"2017","journal-title":"Int J Drug Policy"},{"key":"2025073012505501000_11.1.e001560.35","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14799","article-title":"An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care","volume":"39","author":"Gracen","year":"2022","journal-title":"Diabet Med"},{"key":"2025073012505501000_11.1.e001560.36","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/tbm\/ibz080","article-title":"Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study","volume":"10","author":"Hallsworth","year":"2020","journal-title":"Transl Behav Med"},{"key":"2025073012505501000_11.1.e001560.37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-1"},{"key":"2025073012505501000_11.1.e001560.38","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S2468-1253(22)00020-6","article-title":"Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic review","volume":"7","author":"Abeysekera","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025073012505501000_11.1.e001560.39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(19)32908-3","article-title":"Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK","volume":"395","author":"Williams","year":"2020","journal-title":"The Lancet"},{"key":"2025073012505501000_11.1.e001560.40","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2015-100617"},{"key":"2025073012505501000_11.1.e001560.41","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30129"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2024-001560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T19:51:08Z","timestamp":1753905068000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2024-001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,11,12]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/bmjgast-2024-001560"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2024-001560","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}